NASDAQ · Financial Statements

WORK Medical Technology Group LTD (WOK) Financial Statements

$1.11 NASDAQ: WOK Market Cap $2.68M

WORK Medical Technology Group LTD most recently reported annual revenue of $10.0M, a net loss of $1.0M. Revenue declined at an average annual rate of 28.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

WORK Medical Technology Group LTD: Revenue fell from $53.0M in 2020 to $10.0M in 2025, a change of -81.1% over 5 years; net profit was positive in 3 of 6 reported years; operating margin moved from 11.4% to -25.3%, a shift of -36.7 percentage points; the most recent year shows a net loss of $1.0M.

Income Statement — 6 Years (USD millions)

Metric202020212022202320242025
Revenue$53.0M$46.0M$20.0M$14.0M$12.0M$10.0M
Operating Expenses$47.0M$38.0M$18.0M$13.0M$15.0M$12.0M
Operating Profit$6.0M$8.0M$2.0M$0$-4.0M$-2.0M
Operating Margin11.4%16.7%9.3%3.6%-32.1%-25.3%
Other Income$-5.0M$3.0M$0$0$0$1.0M
Interest$0$0$0$0$1.0M$1.0M
Depreciation$3.0M$4.0M$3.0M$2.0M$1.0M$1.0M
Profit Before Tax$1.0M$7.0M$1.0M$0$-4.0M$-1.0M
Tax$8.2M$14.7M$15.2M$42.6M$3.4M$-11.0M
Net Profit$1.0M$6.0M$1.0M$0$-3.0M$-1.0M
EPS$1.16$48.00$6.92$0.90$-27.00$-37.01
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 7 Quarters (USD millions)

MetricMar '23Sep '23Mar '24Sep '24Mar '25Sep '25Mar '26
Revenue$9.0M$5.0M$5.0M$6.0M$5.0M$5.0M$5.0M
Operating Expenses$7.0M$6.0M$6.0M$10.0M$6.0M$6.0M$9.0M
Operating Profit$2.0M$-2.0M$-1.0M$-4.0M$-2.0M$-1.0M$-4.0M
Operating Margin22.3%-33.4%-9.6%-57.1%-34.5%-17.5%-65.3%
Interest$0$0$0$0$0$0$0
Profit Before Tax$1.0M$-1.0M$0$-4.0M$0$-1.0M$-3.0M
Tax$-9.7M$-14.5M$7.9M$-4.0M$75.7M$-21.9M$0
Net Profit$1.0M$-1.0M$0$-4.0M$0$-1.0M$-3.0M
EPS$12.00$-11.00$1.81$-29.00$0.09$-10.48$-197.76

Over the 6 years reported for WORK Medical Technology Group LTD, borrowings increased from $4.0M in 2020 to $6.0M in 2025, cash stood at $4.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.67 times.

Balance Sheet — 6 Years (USD millions)

Metric202020212022202320242025
Total Assets$56.0M$31.0M$26.0M$30.0M$36.0M$33.0M
Current Assets$40.0M$18.0M$17.0M$22.0M$21.0M$20.0M
Cash$0$1.0M$1.0M$2.0M$7.0M$4.0M
Inventory$13.0M$6.0M$4.0M$5.0M$3.0M$4.0M
Receivables$1.0M$7.0M$6.0M$11.0M$6.0M$12.0M
Fixed Assets$15.0M$11.0M$8.0M$7.0M$14.0M$11.0M
Capital Work in Progress$0$0$0$0$0$0
Investments$0$0$0$0$0$0
Other Assets$0$0$0$0$0$0
Total Liabilities$50.0M$19.0M$14.0M$19.0M$20.0M$12.0M
Current Liabilities$50.0M$19.0M$14.0M$19.0M$20.0M$12.0M
Borrowings$4.0M$7.0M$6.0M$9.0M$13.0M$6.0M
Other Liabilities$46.0M$13.0M$8.0M$10.0M$7.0M$6.0M
Equity$0$0$0$0$0$0
Reserves$5.0M$10.0M$10.0M$10.0M$13.0M$18.0M

For WORK Medical Technology Group LTD, operating cash flow was positive in 3 of 6 reported years; free cash flow in the latest year was $5.0M; free cash flow was positive in 3 of 6 years; financing activities used $2.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 6 Years (USD millions)

Metric202020212022202320242025
Operating Cash Flow$27.0M$-7.0M$-2.0M$2.0M$-2.0M$6.0M
Investing Cash Flow$-34.0M$0$-3.0M$-1.0M$-18.0M$-9.0M
Financing Cash Flow$-3.0M$5.0M$13.0M$-4.0M$7.0M$-2.0M
Net Cash Flow$0$1.0M$0$1.0M$5.0M$-3.0M
Free Cash Flow$10.0M$-7.0M$-4.0M$2.0M$-11.0M$5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-2.17
FCF Yield-158.76%
Quick Ratio0.82
Interest Coverage-13.35
Return 1Y-100.00%
Return 3Y—
Return 5Y—

WORK Medical Technology Group LTD (WOK) financials — frequently asked questions

What is WORK Medical Technology Group LTD's annual revenue?

WORK Medical Technology Group LTD (WOK) reported annual revenue of $10.0M in its most recent fiscal year.

What is WORK Medical Technology Group LTD's net profit?

WORK Medical Technology Group LTD (WOK) reported a net loss of $1.0M in its most recent fiscal year.

What is WOK EV/EBITDA?

WORK Medical Technology Group LTD's enterprise value to EBITDA (EV/EBITDA) ratio is -2.17. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
WOK Overview WOK Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.